673 related articles for article (PubMed ID: 19605798)
21. ASHP guidelines on compounding sterile preparations.
American Society of Health System Pharmacists
Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608
[No Abstract] [Full Text] [Related]
22. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
Allen LV
Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
[TBL] [Abstract][Full Text] [Related]
23. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
[No Abstract] [Full Text] [Related]
24. Impact of United States Pharmacopeia chapter 797: results of a national survey.
Candy TA; Schneider PJ; Pedersen CA
Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an aseptic technique testing and challenge kit (ATTACK).
Turco S; Miele WH; Barnoski D
Hosp Pharm; 1993 Jan; 28(1):11-3, 16-8. PubMed ID: 10124004
[TBL] [Abstract][Full Text] [Related]
26. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
Crawford SY; Narducci WA; Augustine SC
Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
[TBL] [Abstract][Full Text] [Related]
27. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
Lin SY; Houser SM; Gross G; Aaronson D
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive intravenous admixture services: logistics and quality assurance in a university affiliated teaching institution.
Wellman GS; Hale KM; Schneider PJ; Hale KN
Hosp Pharm; 1984 Sep; 19(9):601-6. PubMed ID: 10267935
[TBL] [Abstract][Full Text] [Related]
29. The potential impact of USP 797 and what the JCAAI is doing about it.
Nathan R
Allergy Asthma Proc; 2007; 28(2):236-7. PubMed ID: 17479611
[No Abstract] [Full Text] [Related]
30. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
Marks Z
Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
[TBL] [Abstract][Full Text] [Related]
31. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
Vu N; Nguyen K; Kupiec TC
Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
[TBL] [Abstract][Full Text] [Related]
32. [Development of patient related parenteral nutrition solutions].
Schroeder W
Beitr Infusionther Klin Ernahr; 1986; 14():79-81. PubMed ID: 3096304
[No Abstract] [Full Text] [Related]
33. Sterility of extemporaneously compounded preservative-free injections.
Levchuk JW
Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
[No Abstract] [Full Text] [Related]
34. Parenteral nutrition in hospital pharmacies.
Katoue MG; Al-Taweel D; Matar KM; Kombian SB
Int J Health Care Qual Assur; 2016 Jul; 29(6):664-74. PubMed ID: 27298063
[TBL] [Abstract][Full Text] [Related]
35. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
[TBL] [Abstract][Full Text] [Related]
36. Quality of extemporaneously compounded nitroglycerin ointment.
Azarnoff DL; Lee JC; Lee C; Chandler J; Karlin D
Dis Colon Rectum; 2007 Apr; 50(4):509-16. PubMed ID: 17476559
[TBL] [Abstract][Full Text] [Related]
37. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
[TBL] [Abstract][Full Text] [Related]
38. Implementation of safe practices for parenteral nutrition formulations. American Society Parenteral and Enteral Nutrition.
Kumpf VJ
Am J Health Syst Pharm; 1999 Apr; 56(8):815-7. PubMed ID: 10326617
[No Abstract] [Full Text] [Related]
39. Parenteral nutrition training for the pharmacy team: focus on pharmacy technicians.
Cassano AT
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):48S-50S. PubMed ID: 22275327
[TBL] [Abstract][Full Text] [Related]
40. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions.
Bonnabry P; Cingria L; Sadeghipour F; Ing H; Fonzo-Christe C; Pfister RE
Qual Saf Health Care; 2005 Apr; 14(2):93-8. PubMed ID: 15805453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
